jump to the main content
jump to the bottom of the page

Contenido en español
Contingut en català
Current language Spanish

COLLABORATE El Meu Clínic

Contenido en español
Contingut en català
Current language Spanish

Neus Agell

Research group

Signal transduction, intracellular compartments and cancer Group leader (R4-UB)

neusagell@ub.edu 0000-0002-1205-6074

Follow it on:

The Researchgate of Neus . This link opens in a new tab.

Featured publications

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds

Authors:
Pallara, Chiara; Cabot, Debora; Rivas, Josep; Brun, Sonia; Seco, Jesus;

Abuasaker, Baraa; Tarrago, Teresa; Jaumot, Montserrat; Prades, Roger; Agell, Neus.

Reference: Scientific Reports 2022.
KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer

Authors:
Cabot, Debora; Brun, Sonia; Paco, Noelia; Ginesta, Mireia M; Gendrau-Sanclemente, Nuria;

(...)

Pons, Gabriel; Estanyol, Josep M; Capella, Gabriel; Jaumot, Montserrat; Agell, Neus.

Reference: Oncogene 2021.
Acute hydroxyurea-induced replication blockade results in replisome components disengagement from nascent DNA without causing fork collapse

Authors:
Ercilla A; Feu S; Aranda S; Llopis A; Brynjólfsdóttir SH;

Sørensen CS; Toledo LI; Agell N.

Reference: Cellular And Molecular Life Sciences 2020.

Featured Projects

Molécula activadora de la señalizacion de KRAS oncogénico como terapia dirigida contra cáncer colorectal

Principal investigator: Neus Agell Jane

Funder: Ministerio de Ciencia e Innovación

Code: PDC2022-133653-I00

Duration: 01/12/2022
A peptidemimetic inhibidor of RAS as targeted therapy for pancreatic cancer

Principal investigator: Neus Agell Jane

Funder: Fundacio Bosch i Gimpera

Duration: 08/01/2022 - 01/04/2023
Peptidomiméticos inhibidores de KRAS como terapia dirigida para el cancer de páncreas

Principal investigator: Neus Agell Jane

Funder: Ministerio de Ciencia e Innovación

Code: PDC2021-121119-I00

Duration: 01/12/2021 - 30/11/2023
Nuevas interacciones de KRAS relevantes para su actividad oncogénica y efecto del estrés de replicación en la actividad transcripcional

Principal investigator: Neus Agell Jane

Funder: Ministerio de Ciencia e Innovación

Code: PID2019-105483RB-I00

Duration: 01/01/2020 - 01/07/2023